Get the Stockscreener App
30.50
0.97%
-0.30
After Hours:
31.11
0.61
+2.00%
Vera Therapeutics Inc stock is traded at $30.50, with a volume of 1.25M.
It is down -0.97% in the last 24 hours and up +23.23% over the past month.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
See More
Previous Close:
$30.80
Open:
$31.14
24h Volume:
1.25M
Relative Volume:
0.85
Market Cap:
$1.95B
Revenue:
-
Net Income/Loss:
$-107.85M
P/E Ratio:
-13.80
EPS:
-2.21
Net Cash Flow:
$-106.82M
1W Performance:
+5.94%
1M Performance:
+23.23%
6M Performance:
+61.72%
1Y Performance:
-21.07%
1-Day Range:
$30.38
$31.80
1-Week Range:
$28.50
$31.80
52-Week Range:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Name
Vera Therapeutics Inc
Sector
Industry
Phone
650-770-0077
Address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
30.50 | 1.97B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| May-05-25 | Resumed | H.C. Wainwright | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Jan-28-25 | Initiated | Goldman | Buy |
| Nov-21-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-25-24 | Initiated | Oppenheimer | Outperform |
| Jan-08-24 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-18-23 | Initiated | Raymond James | Outperform |
| Nov-10-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-16-23 | Initiated | Guggenheim | Buy |
| Jan-04-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-04-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-12-22 | Initiated | JP Morgan | Overweight |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-22 | Initiated | Wedbush | Outperform |
View All
Vera Therapeutics Inc Stock (VERA) Latest News
Using RSI to spot recovery in Vera Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Heatmap analysis for Vera Therapeutics Inc. and competitorsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Will Vera Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Why Vera Therapeutics Inc. stock could rally in 2025July 2025 Price Swings & Verified Entry Point Signals - newser.com
Is Vera Therapeutics Inc. stock overvalued by current metricsOptions Play & Free Growth Oriented Trading Recommendations - newser.com
Risk vs reward if holding onto Vera Therapeutics Inc.2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com
J. Safra Sarasin Holding AG Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Evaluating Vera Therapeutics Inc. with trendline analysisJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Developing predictive dashboards with Vera Therapeutics Inc. dataJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
What drives Vera Therapeutics Inc stock priceLong-Term Growth Stocks & These Stocks Are Just Getting Started - earlytimes.in
Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛
Vera Therapeutics, Inc. $VERA Shares Purchased by Platinum Investment Management Ltd. - MarketBeat
13,567 Shares in Vera Therapeutics, Inc. $VERA Acquired by GC Wealth Management RIA LLC - MarketBeat
Fifth Third Bancorp Buys New Stake in Vera Therapeutics, Inc. $VERA - Defense World
10,406 Shares in Vera Therapeutics, Inc. $VERA Purchased by Perigon Wealth Management LLC - MarketBeat
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating - 富途牛牛
What analysts say about Vera Therapeutics Inc stockDividend Reinvestment Plans & Low Risk Investment Tips - earlytimes.in
Vera Therapeutics Inc Stock Analysis and ForecastHigh Beta Stocks & Small Entry Investment Ideas - Early Times
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Vera Therapeutics (VERA): Assessing Valuation After New KDIGO Guidelines Shape the IgA Nephropathy Market - Sahm
Vera Therapeutics, Inc. (VERA) Stock Analysis: Unpacking A 140% Potential Upside - DirectorsTalk Interviews
LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛
Is Vera Therapeutics (VERA) Positioned to Benefit Most from Expanding IgA Nephropathy Treatment Guidelines? - Sahm
Pullback Watch: Is Vera Therapeutics Inc stock overvalued or fairly pricedJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - khodrobank.com
Voya Investment Management LLC Has $15.07 Million Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Dow Update: How correlated is Vera Therapeutics Inc to the S P5002025 Volume Leaders & Daily Profit Maximizing Trade Tips - خودرو بانک
Dynamic Technology Lab Private Ltd Takes $326,000 Position in Vera Therapeutics, Inc. $VERA - MarketBeat
What technical models suggest about Vera Therapeutics Inc.’s comeback2025 Top Gainers & Real-Time Market Trend Scan - newser.com
Panic Selling: Is Baidu Inc. Depositary Receipt forming a double bottomMarket Risk Summary & Low Risk Profit Maximizing Plans - خودرو بانک
Day Trade: Is Vera Therapeutics Inc stock overvalued or fairly pricedQuarterly Growth Report & Fast Entry High Yield Stock Tips - خودرو بانک
Vera Therapeutics, Inc. $VERA Shares Sold by Siren L.L.C. - MarketBeat
Quarterly Risk: What is the earnings history of Vera Therapeutics IncTrade Analysis Summary & Community Verified Trade Signals - خودرو بانک
Insider Sell: What is the earnings history of Vera Therapeutics IncJuly 2025 Sentiment & Low Risk High Reward Ideas - khodrobank.com
Woodline Partners LP Sells 201,617 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Treasury Yields: How correlated is Vera Therapeutics Inc to the S P5002025 Dividend Review & Intraday High Probability Setup Alerts - خودرو بانک
Vera Therapeutics Inc Stock (VERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vera Therapeutics Inc Stock (VERA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):